Filing Details

Accession Number:
0001562180-22-005181
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-17 15:33:24
Reporting Period:
2022-06-16
Accepted Time:
2022-06-17 15:33:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1822791 Clene Inc. CLNN Pharmaceutical Preparations (2834) 852828339
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1835427 Mark Mortenson 6550 South Millrock Drive
Suite G50
Salt Lake City UT 84121
Chief Science Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-06-16 20,247 $2.47 168,759 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 represent shares of common stock of Clene Inc. required to by sold by Mr. Mortenson to satisfy tax withholding obligations in connection with the vesting of 50,082 restricted stock awards. The sale occurred automatically to satisfy the tax withholding obligation to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.